
|Articles|November 11, 2016 (Updated: January 4, 2022)
IMDC Prognostic Category May Predict Treatment Course for Metastatic RCC Patients
Author(s)Bobby Lazzara, MD
A recent study published in European Urology suggests that patterns of treatment failure might help to predict what the next treatment should be for patients with metastatic renal cell carcinoma.
Advertisement
A recent study
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Traditional Approval to Encorafenib in BRAF-Mutated CRC
2
Nivolumab/Chemo Yields Long-Term Survival in Advanced Gastric Cancers
3
FDA Grants Fast Track Designation to ART6043/Olaparib in BRCA-Mutated, HER2– Breast Cancer
4
Evaluating the Cost-Effectiveness of Immunotherapy in Lung Cancers
5












































